Speciality pharmaceutical company Special Products Ltd has changed its name to Veriton Pharma Ltd.

The company says that the name change reflects its heritage combined with its future ambition to make trusted medicines available for everyday living.

Headquartered in Weybridge, Veriton Pharma is a privately-owned company, which also has regional offices in the Middle East and Australia. It sources and supplies licensed medicines for CNS and over 75 high-quality, UK batch manufactured unlicensed medicines in the fields of epilepsy, neurology and rare paediatric conditions.

Chris Grimes, chief commercial officer commented: “With the launch of Epistatus® 10mg in 1mL Oromucosal Solution Midazolam (as maleate) and our extensive range of existing unlicensed medicines, we would like to assure our customers and partners that the excellent service and quality they have come to expect from us as a company will continue and all contacts at the company will remain the same.”